CBD vs. THC: understand the differences
CBD and THC are different cannabinoids found in cannabis. THC can cause intoxication; CBD does not produce the same high, but is not risk-free. Evidence applies to particular products and conditions, not to every oil or edible. Prescription cannabinoid medicines should not be confused with retail wellness products. [1–3]
Understand CBD and THC, prescription cannabinoid medicines, product differences and the limits of evidence for sleep, anxiety and pain.
Separate the compound, the product and the claim.
Key takeaways
- THC and CBD are not interchangeable, and a mixture is a different product again.
- A prescription medicine's approval does not validate every product containing the same compound.
- Look for human studies of the actual formulation and outcome being claimed.
- For personal treatment decisions, review the evidence and risks with a qualified clinician.
CBD, THC and cannabis are different terms
Cannabis is the plant; cannabinoids are compounds it contains. Delta-9 THC is chiefly responsible for the familiar cannabis high. CBD lacks that same intoxicating effect, although it can still affect alertness and interact with medicines. A label saying CBD does not establish that a product contains no THC. [2,3]
For a useful comparison, write down both the compound and the formulation. An oral oil, a prescription capsule and an inhaled plant product are not equivalent simply because the same letters appear on the packaging.
Prescription medicines: a separate evidence category
FDA identifies four approved cannabis-derived or cannabis-related prescription medicines: Epidiolex (cannabidiol), Marinol and Syndros (dronabinol), and Cesamet (nabilone). Their approvals concern defined medical indications, including certain seizure disorders and, for particular products, chemotherapy-related nausea or AIDS-related appetite loss. They are not general approvals of cannabis for wellness. [1]
When reading a product claim, ask which exact medicine, condition and formulation the evidence describes. A retailer referring to an approved ingredient is not the same as offering an approved medicine.
Sleep and anxiety: avoid turning a possibility into a promise
A 2024 randomized pilot trial involving 30 adults with insomnia compared CBD with placebo for two weeks. Most sleep outcomes, including insomnia severity, did not differ between groups, although some secondary findings favored CBD. This small, short trial does not settle long-term effectiveness or establish a dose for self-treatment. [5]
NCCIH describes limited anxiety research. A result in a small experimental study cannot establish routine treatment for an anxiety disorder. THC-containing cannabis can itself produce anxiety or paranoia. [2,6]
Pain findings do not transfer to every product
The AHRQ 2025 review found small short-term pain improvements with some THC-containing products, largely in neuropathic pain, alongside more dizziness, sedation or nausea. CBD alone did not improve pain or function in the included trials. Evidence for whole-plant cannabis, topical CBD and longer-term outcomes remained insufficient. [4]
That means a headline about cannabis and pain cannot answer whether a particular cream will help knee arthritis or whether a retail oil will help back pain. Those are different questions about different products and populations.
How to read a comparison without buying into a claim
Try this three-column note when reading an article or advertisement: what was tested, what changed, and what remains unknown. For example, if an article describes a short trial of an oral formulation, place the route and study duration in the first column. Put the actual measured outcome in the second, rather than a broad phrase such as better wellness. Leave unanswered questions visible in the third.
- Was the source a human controlled trial, an observational study, an animal experiment or a testimonial?
- Did the study measure the outcome you care about, or only a laboratory marker?
- Does the article report unwanted effects as well as benefits?
- Is the author describing the studied product, or selling a different one?
Choose the next useful step
Use the companion evidence and safety guide to prepare a conversation with a clinician or pharmacist. For sleep routines, Beiing's sleep resources and calculator are planning tools, not cannabinoid recommendations. No page here selects a product, recommends a dose or checks whether a medicine combination is safe.
Frequently asked questions
Is CBD the same as medical cannabis?
No. CBD is one compound. Medical cannabis can describe different products and arrangements for access; that wording does not make a retail product equivalent to an FDA-approved medicine.
Does CBD counteract every effect of THC?
Do not assume that adding CBD makes a THC product safe or removes impairment. The overall formulation and its evidence matter; this guide cannot predict an individual's response.
Are CBN and CBG interchangeable with CBD?
No. They are different compounds. Findings about CBD or THC do not establish the effects, safety or usefulness of a CBN or CBG product.
Related on Beiing
Sources
- [1] FDA: Cannabis research and drug approval - U.S. Food and Drug Administration
- [2] Cannabis and cannabinoids: What you need to know - NCCIH / NIH
- [3] FDA: CBD safety, side effects and unknowns - U.S. Food and Drug Administration
- [4] Living systematic review of cannabis for chronic pain: 2025 update - Agency for Healthcare Research and Quality
- [5] Narayan et al. (2024): Randomized pilot trial of CBD for insomnia - Journal of Clinical Sleep Medicine
- [6] Cannabis and mental health - Centers for Disease Control and Prevention
Written by Beiing Editorial Team · Editorially reviewed by Beiing Editorial & Research Review · Published · Last reviewed . Editorial and research review by Beiing writers and researchers. This is not medical or clinical review, and no clinician signs off on our content.
Educational content only - not medical advice. In a crisis, call or text 988 (US) or your local emergency number. See crisis resources.